220 related articles for article (PubMed ID: 19053759)
1. Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization.
Barinka C; Byun Y; Dusich CL; Banerjee SR; Chen Y; Castanares M; Kozikowski AP; Mease RC; Pomper MG; Lubkowski J
J Med Chem; 2008 Dec; 51(24):7737-43. PubMed ID: 19053759
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.
Barinka C; Hlouchova K; Rovenska M; Majer P; Dauter M; Hin N; Ko YS; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
J Mol Biol; 2008 Mar; 376(5):1438-50. PubMed ID: 18234225
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of P1'-diversified urea-based inhibitors of glutamate carboxypeptidase II.
Pavlicek J; Ptacek J; Cerny J; Byun Y; Skultetyova L; Pomper MG; Lubkowski J; Barinka C
Bioorg Med Chem Lett; 2014 May; 24(10):2340-5. PubMed ID: 24731280
[TBL] [Abstract][Full Text] [Related]
4. Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities.
Novakova Z; Cerny J; Choy CJ; Nedrow JR; Choi JK; Lubkowski J; Berkman CE; Barinka C
FEBS J; 2016 Jan; 283(1):130-43. PubMed ID: 26460595
[TBL] [Abstract][Full Text] [Related]
5. Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II.
Tykvart J; Schimer J; Jančařík A; Bařinková J; Navrátil V; Starková J; Šrámková K; Konvalinka J; Majer P; Šácha P
J Med Chem; 2015 May; 58(10):4357-63. PubMed ID: 25923815
[TBL] [Abstract][Full Text] [Related]
6. Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II.
Barinka C; Rovenská M; Mlcochová P; Hlouchová K; Plechanovová A; Majer P; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
J Med Chem; 2007 Jul; 50(14):3267-73. PubMed ID: 17567119
[TBL] [Abstract][Full Text] [Related]
7. Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity.
Plechanovová A; Byun Y; Alquicer G; Skultétyová L; Mlčochová P; Němcová A; Kim HJ; Navrátil M; Mease R; Lubkowski J; Pomper M; Konvalinka J; Rulíšek L; Bařinka C
J Med Chem; 2011 Nov; 54(21):7535-46. PubMed ID: 21923190
[TBL] [Abstract][Full Text] [Related]
8. Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III.
Hlouchova K; Barinka C; Konvalinka J; Lubkowski J
FEBS J; 2009 Aug; 276(16):4448-62. PubMed ID: 19678840
[TBL] [Abstract][Full Text] [Related]
9. Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.
Wang H; Byun Y; Barinka C; Pullambhatla M; Bhang HE; Fox JJ; Lubkowski J; Mease RC; Pomper MG
Bioorg Med Chem Lett; 2010 Jan; 20(1):392-7. PubMed ID: 19897367
[TBL] [Abstract][Full Text] [Related]
10. Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis.
Mlcochová P; Plechanovová A; Barinka C; Mahadevan D; Saldanha JW; Rulísek L; Konvalinka J
FEBS J; 2007 Sep; 274(18):4731-41. PubMed ID: 17714508
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.
Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH
J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
[TBL] [Abstract][Full Text] [Related]
13. Carborane-containing urea-based inhibitors of glutamate carboxypeptidase II: Synthesis and structural characterization.
Youn S; Kim KI; Ptacek J; Ok K; Novakova Z; Kim Y; Koo J; Barinka C; Byun Y
Bioorg Med Chem Lett; 2015 Nov; 25(22):5232-6. PubMed ID: 26459214
[TBL] [Abstract][Full Text] [Related]
14. Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity.
Novakova Z; Wozniak K; Jancarik A; Rais R; Wu Y; Pavlicek J; Ferraris D; Havlinova B; Ptacek J; Vavra J; Hin N; Rojas C; Majer P; Slusher BS; Tsukamoto T; Barinka C
J Med Chem; 2016 May; 59(10):4539-50. PubMed ID: 27074627
[TBL] [Abstract][Full Text] [Related]
15. Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA.
Mesters JR; Henning K; Hilgenfeld R
Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):508-13. PubMed ID: 17372356
[TBL] [Abstract][Full Text] [Related]
16. S1 pocket of glutamate carboxypeptidase II: a new binding site for amyloid-β degradation.
Lee SK; Kim H; Cheong YH; Kim MJ; Jo SA; Youn HS; Park SI
Biochem Biophys Res Commun; 2013 Sep; 438(4):765-71. PubMed ID: 23891752
[TBL] [Abstract][Full Text] [Related]
17. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.
Mesters JR; Barinka C; Li W; Tsukamoto T; Majer P; Slusher BS; Konvalinka J; Hilgenfeld R
EMBO J; 2006 Mar; 25(6):1375-84. PubMed ID: 16467855
[TBL] [Abstract][Full Text] [Related]
18. Glutamate carboxypeptidase II: an overview of structural studies and their importance for structure-based drug design and deciphering the reaction mechanism of the enzyme.
Pavlícek J; Ptácek J; Barinka C
Curr Med Chem; 2012; 19(9):1300-9. PubMed ID: 22304708
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.
Ferraris DV; Shukla K; Tsukamoto T
Curr Med Chem; 2012; 19(9):1282-94. PubMed ID: 22304717
[TBL] [Abstract][Full Text] [Related]
20. Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors.
Barinka C; Novakova Z; Hin N; Bím D; Ferraris DV; Duvall B; Kabarriti G; Tsukamoto R; Budesinsky M; Motlova L; Rojas C; Slusher BS; Rokob TA; Rulíšek L; Tsukamoto T
Bioorg Med Chem; 2019 Jan; 27(2):255-264. PubMed ID: 30552009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
